SALVATORE PUCCIARELLI

Full Professor of Surgery

University of Padova

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Salvatore Pucciarelli is a Full Professor of Surgery at the University of Padova, Italy. His research areas include colorectal cancer, surgical techniques, and the role of microbiota in cancer risk assessment, as evidenced by his recent publications. He has contributed significantly to the understanding of cancer treatment outcomes, predictive modeling in oncology, and surgical resection strategies.

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Collaborators (11)

Alberto Biondi

Professore Associato

Università Cattolica del Sacro Cuore

ITALY

View details

Silvia Negro

University of Padua

ITALY

View details

Renato Micelli Lupinacci

FRANCE

View details

Francesco Marchegiani

Università degli Studi della Campania Luigi Vanvitelli Scuola di Medicina e Chirurgia

ITALY

View details

Gaya Spolverato

University of Padua

ITALY

View details

Matteo Fassan

ITALY

View details

Marco Scarpa

ITALY

View details

Marco Vitellaro

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Eloy Espin-Basany

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

Emilio Quaia

Full Professor

University of Padua

ITALY

View details

Filippo Crimì

University of Padua

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

SALVATORE PUCCIARELLI

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Circulating Tumor DNA as a Real-Time Biomarker for Minimal Residual Disease and Recurrence Prediction in Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis

Robotic, transanal, and laparoscopic total mesorectal excision for locally advanced mid/low rectal cancer: European multicentre, propensity score-matched study

Locoregional Recurrence in the RAPIDO Trial and the Importance of the Quality of the Resected Specimen: Does Surgical Resection Matter?

A Machine Learning Model Based on MRI Radiomics to Predict Response to Chemoradiation Among Patients with Rectal Cancer

Trends in colorectal cancer surgical resection rates during the screening era: A retrospective study in Italy

Predictive Value of a Gastric Microbiota Dysbiosis Test for Stratifying Cancer Risk in Atrophic Gastritis Patients

Impact of neoadjuvant chemoradiotherapy on pathologic response in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis

Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancer

Oncological outcomes of patients not undergoing Total Mesorectal Excision after local excision: rethinking surgical indications

Resident Esophageal Microbiota Dysbiosis Correlates with Cancer Risk in Barrett’s Esophagus Patients and Is Linked to Low Adherence to WCRF/AICR Lifestyle Recommendations

Molecular Determinants of Peritoneal Dissemination in Gastric Adenocarcinoma

Association between Pancreatoblastoma and Familial Adenomatous Polyposis: Review of the Literature with an Additional Case

A nomogram to predict overall survival and disease-free survival after curative-intent gastrectomy for gastric cancer

The management of surgical patients during the coronavirus disease 2019 (COVID-19) pandemic

Isoperistaltic Jejunal Loop Interposition after Total Gastrectomy for Gastric Cancer in Patients with Familial Adenomatous Polyposis

Collaborators (11)

Alberto Biondi

Silvia Negro

Renato Micelli Lupinacci

Francesco Marchegiani

Gaya Spolverato

Matteo Fassan

Marco Scarpa

Marco Vitellaro

Eloy Espin-Basany

Emilio Quaia

Filippo Crimì

Make your next move.